Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.
Patricia R. Salber, MD, MBA
Advertisement
Articles by Patricia R. Salber, MD, MBA
Advertisement
Latest Updated Articles
- Screening for Colorectal Cancer: The Business Case
June 1st 2002
- Impact of Dementia on Costs of Modifiable Comorbid Conditions
November 8th 2018
Advertisement
Advertisement
Trending on AJMC
1
Health Care Is Fixable: Workers’ Compensation Shows Employers Don’t Need to Wait for Washington
2
FDA Issues Complete Response Letter for Cytisinicline NDA, Citing Manufacturing Deficiencies
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
A Case for SGLT2 Inhibitors in Non-Diabetic CKD: Sandra Chaparro, MD
5